WHO Endorses Protocol For Coronavirus Herbal Medicine Trials

WHO endorsed protocol for testing African natural medicines as potential therapies for coronavirus

Brazzaville, Congo:

The World Health Organization endorsed Saturday a protocol for testing African natural medicines as potential therapies for the coronavirus and different epidemics.

Covid-19 has raised the problem of utilizing conventional medicines to battle up to date ailments, and the endorsement clearly inspired testing with standards just like these used for molecules developed by labs in Asia, Europe or the Americas.

It got here months after a bid by the president of Madagascar to advertise a drink primarily based on artemisia, a plant with confirmed efficacy in malaria remedy, was met with widespread scorn.

On Saturday, WHO specialists and colleagues from two different organisations “endorsed a protocol for phase III clinical trials of herbal medicine for Covid-19 as well as a charter and terms of reference for the establishment of a data and safety monitoring board for herbal medicine clinical trials,” a press release stated.

“Phase III clinical trials are pivotal in fully assessing the safety and efficacy of a new medical product,” it famous.

“If a traditional medicine product is found to be safe, efficacious and quality-assured, WHO will recommend (it) for a fast-tracked, large-scale local manufacturing,” Prosper Tumusiime, a regional WHO director, was quoted as saying.

WHO’s companions are the Africa Centre for Disease Control and Prevention and the African Union Commission for Social Affairs.

“The onset of Covid-19, like the Ebola outbreak in West Africa, has highlighted the need for strengthened health systems and accelerated research and development programmes, including on traditional medicines,” Tumusiime stated.

He didn’t refer particularly to the Madagascar drink Covid-Organics, additionally known as CVO, that President Andry Rajoelina has pitched as a remedy for the virus, nonetheless.

It has has been extensively distributed in Madagascar and bought to a number of different international locations, primarily in Africa.

In May, WHO Africa Director Matshidiso Moeti advised media that African governments had dedicated in 2000 to taking “traditional therapies” by the identical medical trials as different remedy.

“I can understand the need, the drive to find something that can help,” Moeti stated. “But we would very much like to encourage this scientific process in which the governments themselves made a commitment.”

(Except for the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)


Back to top button